Cost Effectiveness of Pembrolizumab vs. Standard-of-Care Chemotherapy as First-Line Treatment for Metastatic NSCLC that Expresses High Levels of PD-L1 in the United States-Reference-Cited by-同舟云学术

Cost Effectiveness of Pembrolizumab vs. Standard-of-Care Chemotherapy as First-Line Treatment for Metastatic NSCLC that Expresses High Levels of PD-L1 in the United States

Published:2017-06-15 Issue:8 Volume:35 Page:831-844
ISSN:1170-7690
Container-title:PharmacoEconomics
language:en
Short-container-title:PharmacoEconomics

Author:

Huang Min^ORCID,Lou Yanyan,Pellissier James,Burke Thomas,Liu Frank Xiaoqing,Xu Ruifeng,Velcheti Vamsidhar

Funder

Merck & Co. Inc.

Publisher

Springer Science and Business Media LLC

Subject

Public Health, Environmental and Occupational Health,Health Policy,Pharmacology

Link

http://link.springer.com/article/10.1007/s40273-017-0527-z/fulltext.html

Reference52 articles.

1. GLOBOCAN. Estimated Cancer Incidence, Mortality and Prevelance Worldwide in 2012—Lung Cancer. 2012. http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx . Accessed 8 Sept 2016.

2. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69–90.

3. Cancer Research UK. Lung cancer incidence statistics. 2016. http://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/lung-cancer/incidence#heading-Three . Accessed 8 Sept 2016.

4. World Health Organization (WHO): Non-small cell lung cancer. 2014. http://www.who.int/selection_medicines/committees/expert/20/applications/NonSmallCellLungCancer.pdf . Accessed 8 Sept 2016.

5. US Department of Health and Human Services. https://www.fda.gov/drugs/informationondrugs/approveddrugs/ucm526430.htm . Accessed 26 May 2017.

Cited by 113 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bridging the Gap: Immune Checkpoint Inhibitor as an Option in the Management of Advanced and Recurrent Cervical Cancer in Sub-Saharan Africa;Cureus;2024-09-10

2. Analyzing the Spatial Distribution of Immune Cells in Lung Adenocarcinoma;Journal of Personalized Medicine;2024-08-30

3. Review on radiomic analysis in 18F-fluorodeoxyglucose positron emission tomography for prediction of melanoma outcomes;Cancer Imaging;2024-07-05

4. Fully Automated Cassette‐Based Synthesis of 2‐Deoxy‐2‐[¹⁸F]Fluorocellobiose Using Trasis AllInOne Module;Journal of Labelled Compounds and Radiopharmaceuticals;2024-07

5. Cost-effectiveness analysis of durvalumab, tremelimumab, and etoposide-platinum in first-line treatment of extensive-stage small cell lung cancer;Medicine;2024-04-19